Journal of International Medical Research (Oct 2024)

Reduced lipoprotein (a) in patients with severe hypertriglyceridaemia

  • Erin O. Jacob,
  • Adam D. McIntyre,
  • Jian Wang,
  • Robert A. Hegele

DOI
https://doi.org/10.1177/03000605241289294
Journal volume & issue
Vol. 52

Abstract

Read online

Objective To investigate the relationship between plasma lipoprotein (a) (Lp[a]) and lipid profiles in patients with severe hypertriglyceridaemia (HTG). Methods This case–control study undertook a retrospective chart review of patients from the Lipid Genetics Clinic at London Health Sciences Centre in Ontario, Canada. Plasma Lp(a) was compared between patients with severe HTG and healthy normolipidaemic control subjects. Severe HTG was defined by plasma triglycerides (TG) ≥ 10 mmol/l. Pairwise correlations between Lp(a), TG, apolipoprotein B (apo B) and non-high-density lipoprotein cholesterol (non-HDL-C) were evaluated. Results This study reviewed 4400 patients and identified 154 patients with severe HTG, which were compared with 272 control subjects. The median Lp(a) was significantly lower in patients with severe HTG compared with control subjects (5.0 versus 10.2 mg/dl, respectively). No correlation was observed between Lp(a) and TG or non-HDL-C. Lp(a) and apo B were modestly correlated in patients with severe HTG ( r = 0.235) and control subjects ( r = 0.175). There were no significant differences between the genetic subgroups of patients with severe HTG. Conclusions Patients with severe HTG have lower plasma Lp(a) than normolipidaemic control subjects. The basis for this relationship is not immediately apparent but is hypothesis-generating and warrants further investigation.